We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SLDB market cap is 197.61M. The company's latest EPS is USD -1.6091 and P/E is -1.58.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.64M | -26.86M | -27.79M | -35.18M | -39.9M |
| Net Income | -20.34M | -24.3M | -25.07M | -32.73M | -42.6M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 13.62M | 8.09M | 0 | 0 |
| Operating Income | -88.41M | -72.25M | -106.45M | -104.25M | -129.73M |
| Net Income | -88.29M | -72.19M | -85.98M | -96.02M | -124.7M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 164.94M | 248.69M | 230.98M | 211.83M | 188.66M |
| Total Liabilities | 38.46M | 37.97M | 37.74M | 44.8M | 51.42M |
| Total Equity | 126.48M | 210.72M | 193.25M | 167.02M | 137.25M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 171.17M | 232.38M | 260.25M | 164.94M | 188.66M |
| Total Liabilities | 39.08M | 24.17M | 48.59M | 38.46M | 51.42M |
| Total Equity | 132.09M | 208.21M | 211.67M | 126.48M | 137.25M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -94.18M | -25.19M | -46.66M | -70.37M | -100.01M |
| Investing | 9.69M | -38.49M | -43.67M | -54.65M | -16.09M |
| Financing | 3.12M | 107.24M | 112.24M | 115.5M | 122.44M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -56.6M | -77.76M | -97.98M | -94.18M | -100.01M |
| Investing | 6.6M | -91.09M | 59.16M | 9.69M | -16.09M |
| Financing | 128.7M | 134.99M | 74.83M | 3.12M | 122.44M |
| Market Cap | 197.61M |
| Price to Earnings Ratio | -1.58 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.45 |
| Price to Book Ratio | 1.43 |
| Dividend Yield | - |
| Shares Outstanding | 77.49M |
| Average Volume (1 week) | 877.68k |
| Average Volume (1 Month) | 1.13M |
| 52 Week Change | -74.22% |
| 52 Week High | 10.99 |
| 52 Week Low | 2.45 |
| Spread (Intraday) | 0.2 (7.38%) |
| Company Name | Solid Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.solidbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
